[1]
2024. Factors Associated with Persistent Efficacy of Abrocitinib without Flare: A Multivariable Analysis of the JADE-REGIMEN Study. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s378. DOI:https://doi.org/10.25251/skin.8.supp.378.